Our laboratory investigates the epigenetic mechanisms of hematopoietic development and leukemogenesis. We employ genome-wide and targeted profiling of epigenetic marks in combination with functional molecular approaches to elucidate the role of epigenetic mechanisms in normal and malignant blood cells. We also aim to discover predictive epigenetic biomarkers and novel therapeutic targets of disease.